The role of pharmacoeconomic information from the pharmaceutical industry perspective

Drug Benefit Trends

Volumn 13, Issue 3, 2001, Pages 39-45

  Armstrong, E P ^a   Abarca, J ^a   Grizzle, A J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

MCOs; Pharmaceutical industry; Pharmacoeconomics

Indexed keywords

ARTICLE; CLINICAL FEATURE; COST BENEFIT ANALYSIS; DRUG COST; DRUG INDUSTRY; DRUG INFORMATION; INTERVIEW; MANAGED CARE ORGANIZATION; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PHARMACOECONOMICS; QUESTIONNAIRE; UTILIZATION REVIEW;

EID: 0035061685     PISSN: 10805826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Managed care pharmacy, socioeconomic assessments and drug adoption decisions
2. The use of pharmacoeconomic research by MCOs: An actuary's view
3. The view from managed care pharmacy
4. Role of pharmacoeconomics on drug benefit decision making: Results of a survey
5. Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions
6. Conclusions and implications
7. A qualitative assessment of managed care decision makers' view toward and use of pharmacoeconomic information